Editorial
doi: 10.1056/NEJMe0903044.
Epub 2009 Jun 24.
Synthetic lethality--a new direction in cancer-drug development
- PMID: 19553640
- DOI: 10.1056/NEJMe0903044
Item in Clipboard
Editorial
Synthetic lethality--a new direction in cancer-drug development
N Engl J Med.
.
No abstract available
Comment on
-
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.N Engl J Med. 2009 Jul 9;361(2):123-34. doi: 10.1056/NEJMoa0900212. Epub 2009 Jun 24. N Engl J Med. 2009. PMID: 19553641 Clinical Trial.
Similar articles
-
[Olaparib in ovarian cancer with BRCA mutation].Bull Cancer. 2015 Jun;102(6 Suppl 1):S82-4. doi: 10.1016/S0007-4551(15)31221-2. Bull Cancer. 2015. PMID: 26118881 Review. French.
-
[PARP inhibitors and breast cancer: update and perspectives].Bull Cancer. 2012 Apr 1;99(4):441-51. doi: 10.1684/bdc.2012.1553. Bull Cancer. 2012. PMID: 22450359 Review. French.
-
[Hereditary ovarian carcinomas: clinico-biological features and treatment].Bull Cancer. 2014 Feb;101(2):167-74. doi: 10.1684/bdc.2014.1888. Bull Cancer. 2014. PMID: 24555961 Review. French.
-
PARP inhibition in BRCA-mutated breast and ovarian cancers.Lancet. 2010 Jul 24;376(9737):211-3. doi: 10.1016/S0140-6736(10)61119-1. Lancet. 2010. PMID: 20656109 No abstract available.
-
Inhibition of poly(ADP-ribose) polymerase in BRCA mutation carriers.N Engl J Med. 2009 Oct 22;361(17):1707; author reply 1707-8. doi: 10.1056/NEJMc091621. N Engl J Med. 2009. PMID: 19846859 No abstract available.
Cited by
-
Differential chemotherapeutic sensitivity for breast tumors with "BRCAness": a review.Oncologist. 2013;18(8):909-16. doi: 10.1634/theoncologist.2013-0039. Epub 2013 Jul 23. Oncologist. 2013. PMID: 23881989 Free PMC article. Review.
-
CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma.Int J Mol Sci. 2021 May 30;22(11):5869. doi: 10.3390/ijms22115869. Int J Mol Sci. 2021. PMID: 34070839 Free PMC article.
-
A new mutation of BRCA2 gene in an Italian healthy woman with familial breast cancer history.Fam Cancer. 2011 Mar;10(1):65-71. doi: 10.1007/s10689-010-9389-7. Fam Cancer. 2011. PMID: 20878484
-
Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science.Int J Clin Oncol. 2010 Jun;15(3):235-41. doi: 10.1007/s10147-010-0083-4. Epub 2010 May 27. Int J Clin Oncol. 2010. PMID: 20505971 Review.
-
Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways.PLoS Comput Biol. 2013;9(9):e1003226. doi: 10.1371/journal.pcbi.1003226. Epub 2013 Sep 12. PLoS Comput Biol. 2013. PMID: 24068907 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
